Pertussis (Whooping Cough) – Drugs in Development, 2021

Global Markets Direct’s, ‘Pertussis (Whooping Cough) – Drugs in Development, 2021’, provides an overview of the Pertussis (Whooping Cough) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pertussis (Whooping Cough), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pertussis (Whooping Cough) and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

– The report provides a snapshot of the global therapeutic landscape of Pertussis (Whooping Cough)

– The report reviews pipeline therapeutics for Pertussis (Whooping Cough) by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Pertussis (Whooping Cough) therapeutics and enlists all their major and minor projects

– The report assesses Pertussis (Whooping Cough) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Pertussis (Whooping Cough)

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Pertussis (Whooping Cough)

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Pertussis (Whooping Cough) pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Adjuvance Technologies Inc

AIM Vaccine Co Ltd

Beijing Minhai Biotechnology Co Ltd

Beijing Tiantan Biological Products Co Ltd

Bharat Biotech Ltd

Biken Co Ltd

Biological E Ltd

BioNet-Asia Co Ltd

Boryung Pharmaceutical Co Ltd

Cadila Healthcare Ltd

CanSino Biologics Inc

Changchun Bcht Biotechnology Co Ltd

Chongqing Zhifei Biological Products Co Ltd

DBV Technologies SA

Dynavax Technologies Corp

Faron Pharmaceuticals Oy

Gamaleya Federal Research Center of Epidemiology and Microbiology

GC Pharma

GlaxoSmithKline Plc

ILiAD Biotechnologies LLC

KM Biologics Co Ltd

LG Chem Ltd

Novo Medi Sciences Pvt Ltd

Olymvax Biopharmaceuticals Inc

Panacea Biotec Ltd

Sanofi

Serum Institute of India Pvt Ltd

Shantha Biotechnics Pvt Ltd

Suzhou Weichao Biotechnology Co Ltd

Synthetic Biologics Inc

VaxForm LLC

Yisheng Biopharma Co Ltd

Table of Contents

Table of Contents

Introduction

Global Markets Direct Report Coverage

Pertussis – Overview

Pertussis – Therapeutics Development

Pertussis – Therapeutics Assessment

Pertussis – Companies Involved in Therapeutics Development

Pertussis – Drug Profiles

Pertussis – Dormant Projects

Pertussis – Discontinued Products

Pertussis – Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Pertussis (Whooping Cough), 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Companies, 2021 (Contd..1)

Number of Products under Development by Universities/Institutes, 2021

Products under Development by Companies, 2021

Products under Development by Companies, 2021 (Contd..1)

Products under Development by Companies, 2021 (Contd..2)

Products under Development by Universities/Institutes, 2021

Number of Products by Stage and Target, 2021

Number of Products by Stage and Mechanism of Action, 2021

Number of Products by Stage and Route of Administration, 2021

Number of Products by Stage and Molecule Type, 2021

Pertussis (Whooping Cough) – Pipeline by Adjuvance Technologies Inc, 2021

Pertussis (Whooping Cough) – Pipeline by AIM Vaccine Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Beijing Minhai Biotechnology Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Beijing Tiantan Biological Products Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Bharat Biotech Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Biken Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Biological E Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by BioNet-Asia Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Boryung Pharmaceutical Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Cadila Healthcare Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by CanSino Biologics Inc, 2021

Pertussis (Whooping Cough) – Pipeline by Changchun Bcht Biotechnology Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Chongqing Zhifei Biological Products Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by DBV Technologies SA, 2021

Pertussis (Whooping Cough) – Pipeline by Dynavax Technologies Corp, 2021

Pertussis (Whooping Cough) – Pipeline by Faron Pharmaceuticals Oy, 2021

Pertussis (Whooping Cough) – Pipeline by Gamaleya Federal Research Center of Epidemiology and Microbiology, 2021

Pertussis (Whooping Cough) – Pipeline by GC Pharma, 2021

Pertussis (Whooping Cough) – Pipeline by GlaxoSmithKline Plc, 2021

Pertussis (Whooping Cough) – Pipeline by ILiAD Biotechnologies LLC, 2021

Pertussis (Whooping Cough) – Pipeline by KM Biologics Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by LG Chem Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Novo Medi Sciences Pvt Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Olymvax Biopharmaceuticals Inc, 2021

Pertussis (Whooping Cough) – Pipeline by Panacea Biotec Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Sanofi, 2021

Pertussis (Whooping Cough) – Pipeline by Serum Institute of India Pvt Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Shantha Biotechnics Pvt Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Suzhou Weichao Biotechnology Co Ltd, 2021

Pertussis (Whooping Cough) – Pipeline by Synthetic Biologics Inc, 2021

Pertussis (Whooping Cough) – Pipeline by VaxForm LLC, 2021

Pertussis (Whooping Cough) – Pipeline by Yisheng Biopharma Co Ltd, 2021

Pertussis (Whooping Cough) – Dormant Projects, 2021

Pertussis (Whooping Cough) – Dormant Projects, 2021 (Contd..1)

Pertussis (Whooping Cough) – Discontinued Products, 2021

List of Figures

List of Figures

Number of Products under Development for Pertussis (Whooping Cough), 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Universities/Institutes, 2021

Number of Products by Targets, 2021

Number of Products by Stage and Targets, 2021

Number of Products by Mechanism of Actions, 2021

Number of Products by Stage and Mechanism of Actions, 2021

Number of Products by Routes of Administration, 2021

Number of Products by Stage and Routes of Administration, 2021

Number of Products by Top 10 Molecule Types, 2021

Number of Products by Stage and Top 10 Molecule Types, 2021

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2960

Saved reports